News for Walvax Biotechnology Co., Ltd. (300142.SZ)

“Pneumococcal Vaccine Market” from 2024-2034 with covered segments By Vaccine Type (Pneumococcal Conjugate Vaccine and Pneumococcal Polysaccharide...

Visiongain has published a new report entitled Meningococcal Vaccines Market Report 2024-2034: Forecasts by Type (Polysaccharide Vaccines, Conjugate...

Global meningococcal vaccines market is segmented by type, and end-user. The market can be segmented based on type into conjugate and polysaccharide...

A survey by Fortune Business Insights projects that the global cancer vaccines market would grow at a compound annual growth rate (CAGR) of 14.7%, with a...

Visiongain has published a new report entitled Cancer Vaccines Market Report 2023-2033: Forecasts by Type (Preventive Vaccines, Therapeutic Vaccines), by...

As per the report by Fortune Business Insights, The Global Cancer Vaccines Market size is projected to reach USD 19.12 Billion by 2029, at a CAGR of 14.7%...

/PRNewswire/ -- The human combination vaccines market size is set to grow by USD 6046.98 million between 2022 and 2027 and register a CAGR of 8.13%, according...

/PRNewswire/ -- The human papillomavirus (HPV) therapeutics market size is forecasted to increase by USD 953.3 million from 2022 to 2027, at a CAGR of 5.15%,...

According to Fortune Business Insights, Cancer Vaccines Market to Reach USD 19.12 Billion by 2029; Vaccine manufacturers Xiamen Innovax Biotech Co., Ltd....

Visiongain has published a new report entitled Meningococcal Vaccines 2023-2033. It includes profiles of Meningococcal Vaccines and Forecasts Market...

/PRNewswire/ -- The "China Vaccine Market, Size, Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has...

For those of you who are looking to diversify your investment portfolio to invest in the Chinese market, yet at the same time not well-versed in Chinese to study the annual reports of individual companies, the new UOBAM Ping An ChiNext ETF is one you can consider. With this new ETF, you'll be able to get instant access to the ChiNext Market, which is less accessible to foreign retail investors. In this post, you'll learn about the essentials you need to know about this newly launched ETF, which I hope will give you a better understanding at the end of it...

Rise in outbreaks of meningococcal disease, increase in immunization programs across the world, and surge in research and development for vaccine technology drive the global meningococcal vaccine…

/PRNewswire/ -- According to Coherent Market Insights, the global meningitis vaccines market is estimated to be valued at US$ 4,070.1 million in 2022 and is...